ReviewJournal of clinical pharmacy and therapeutics2020

Cardiovascular safety outcomes of once-weekly GLP-1 receptor agonists in people with type 2 diabetes.

Jennifer D GoldmanPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.